基于TCGA数据集分析LINC00900在甲状腺乳头状癌中的表达及临床意义OACSTPCD
Expression and clinical significance of LINC00900 in thyroid papillary carcinoma based on TCGA dataset
目的 研究甲状腺乳头状癌(PTC)中长链非编码 RNA00900(LINC00900)的表达与患者临床病理特征及预后的关系.方法 利用美国癌症基因组图谱(TCGA)数据库收集 PTC 数据资料,下载基因表达谱资料和PTC临床病例信息资料.比较PTC癌组织和癌旁甲状腺组织中LINC00900 的表达.分析LINC00900表达与患者临床病理特征的关系.绘制Kaplan-Meier生存曲线分析LINC00900 表达与PTC患者生存时间的关系.通过加权基因共表达网络分析(WGCNA)预测与 LINC00900 相关的蛋白编码基因(PCGs),利用注释、可视化和集成发现数据库(DAVID)在线注释工具对筛选出的 PCGs 进行基因本体论(GO)和京都基因和基因组百科全书(KEGG)通路分析.结果 LINC00900 在 PTC 癌组织的表达水平显著高于癌旁正常甲状腺组织(P<0.001).不同年龄、病理T分期、组织学类型PTC患者的 LINC00900 表达水平比较,差异均有统计学意义(P<0.05);≥55 岁PTC患者LINC00900 表达水平明显低于<55 岁组(P<0.01);T3~T4 期PTC患者的LINC00900 表达水平明显低于 T1~T2 期(P<0.01);高细胞亚型 PTC 患者 LINC00900 表达水平低于经典型、滤泡型和其他型(P<0.01).Kaplan-Meier 生存曲线结果显示,LINC00900 高表达组 PTC 患者的生存率明显高于低表达组(Log-rankχ2=6.691,P<0.05).功能富集分析结果显示,LINC00900 可能通过核小体装配、mRNA的剪接、组蛋白 H3 甲基化的修饰、染色体绑定、组蛋白乙酰转移酶调节因子活性调节、鞘氨醇-1-磷酸磷酸酶活性调节、黏蛋白型 O-聚糖生物合成等通路影响PTC的进展及预后.结论 在PTC中,LINC00900高表达是一种预后保护因素,可作为辅助判断PTC预后的有效生物标志物之一.
Objective To investigate the expression of long chain non-coding RNA00900(LINC00900)in papillary thyroid carcinoma(PTC),and the relationship between LINC00900 and the clinical characteristics.Methods The Cancer Genome Atlas of America(TCGA)database was utilized to collect PTC data informa-tion,download gene expression profile information and PTC clinical case information information.The expres-sion of LINC00900 between PTC cancer tissues and paracancerous thyroid tissues was compared.The relation-ship between the expression of LINC00900 and clinical characteristics of PTC patients was analyzed.Kaplan-Meier survival curves were plotted to analyze the relationship between LINC00900 expression and survival time of PTC patients.Protein-coding genes(PCGs)associated with LINC00900 were predicted by weighted gene co-expression network analysis(WGCNA),and the screened PCGs were subjected to gene ontology(GO)and Kyoto Encyclopedia of Genomes and Genomes(KEGG)pathway analyses by the Database for An-notation,Visualization and Integrated Discovery(DAVID)online annotation tool.Results The expression level of LINC00900 in PTC cancer tissues was significantly higher than that in normal paracancerous thyroid tissues(P<0.001);the differences of LINC00900 levels in PTC patients with different ages,pathological T stages and histological types were statistically significant(P<0.05);the expression level of LINC00900 in PTC patients≥55 years old was significantly lower than that of PTC patients<55 years(P<0.01);the LINC00900 expression level of PTC patients with T3-T4 stage was significantly lower than that of T1-T2 stage(P<0.01);the LINC00900 expression level of PTC patients with high-cellular subtypes was lower than that of classic,follicular and other types(P<0.01);and the results of the Kaplan-Meier survival curves showed that the survival rate of PTC patients with high-expression of LINC00900 was significantly longer than that of the patients with low-expression of LINC00900(Log-rankχ2=6.691,P<0.05).Functional en-richment analysis showed that LINC00900 might affect the progression and prognosis of PTC through path-ways such as nucleosome assembly,splicing of mRNA,modification of histone H3 methylation,chromosome binding,regulation of histone acetyltransferase regulator activity,regulation of sphingosine-1-phosphate phos-phatase activity,and biosynthesis of mucin-type O-glycans.Conclusion High expression of LINC00900 is a favorable prognostic factor for PTC,and it may be a biomarker in both prognosis and diagnosis for PTC in the future.
黎春;郭陈刚;逯素梅;马万山
山东大学山东省千佛山医院检验部,山东济南 250000||山东省德州市中西医结合医院检验科,山东德州 253000德州学院生物物理研究所/生物物理重点实验室,山东德州 253000山东大学山东省千佛山医院检验部,山东济南 250000
临床医学
甲状腺乳头状癌癌症基因组图谱长链非编码RNALINC00900生存曲线预后
papillary thyroid carcinomaTCGAlncRNALINC00900survival curveprognosis
《检验医学与临床》 2024 (009)
1229-1234 / 6
山东省自然科学基金面上项目(ZR2021MH187).
评论